Our findings strongly indicate that older age and increased BMI should not discourage the use of immunotherapy as a treatment option and underscore the continued viability of PD1/PD-L1 immunotherapy as a first-line treatment for advanced MCC. Here, CD274 is linked to Merkel cell skin cancer.